Gábor Rubovszky - Researcher Profile

Publications

2 shown

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés , David W. Cescon , Hope S. Rugo +97 more

2020 The Lancet 1658 citations

Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

Fabrice André , Eva Ciruelos , Gábor Rubovszky +17 more

Treatment with alpelisib-fulvestrant prolonged progression-free survival among patients with <i>PIK3CA</i>-mutated, HR-positive, HER2-negative advanced breast cancer who had rec...

2019 New England Journal of Medicine 2305 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,963
Institution: National Institute of Oncology

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-1723-5589

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.